S1PR2 and pancreatitis: Pharmacologic inhibition of S1PR2 signaling by JTE-013 or knockdown of S1PR2 expression using a gene-specific shRNA alleviated pancreatic injury and resulted in lower inflammatory responses in caerulein pancreatitis mouse models.